Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06628284
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-29
Brief Title:
CGM As Diagnostic Tool in Observing Steroid-Induced Hyperglycemia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Dexcom CGM As Preventative Diagnostic Tool in Steroid-Induced Hyperglycemia During Interventional Pain Management Procedure
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRC-DX-1
Brief Summary:
This study is designed to help understand how certain steroid medications affect blood sugar levels in patients undergoing pain management treatments Patients who receive steroid injections for conditions like back pain or arthritis experience temporary high blood sugar called steroid-induced hyperglycemia SIH which can sometimes lead to complications especially in patients with diabetes This study aims to understand this by monitoring blood glucose levels using continuous glucose monitors Dexcom G7 The main goal of this study is to track how steroid injections impact blood sugar levels in patients
Detailed Description:
Steroid injections are frequently used in pain management for conditions such as arthritis back pain and joint inflammation While effective at reducing pain and inflammation these steroids can cause temporary spikes in blood sugar known as steroid-induced hyperglycemia This can be a concern especially for patients with diabetes as poorly managed high blood sugar can lead to serious complications This study aims to explore the effects of three commonly used steroids dexamethasone methylprednisolone and triamcinolone each administered at different doses Participants will be fitted with a Dexcom G7 continuous glucose monitor CGM on their arm which will track their blood sugar levels every 5 minutes for up to 10 days
The studys primary objective is to determine how often steroid-induced hyperglycemia occurs how severe it is and how long it lasts Study will also investigate whether certain factors-such as the type of steroid dosage or the patients underlying conditions-affect blood sugar responses Additionally the study will assess how the use of the CGM device may improve overall patient care reduce the need for emergency interventions and potentially lower healthcare costs by preventing complications
By gathering high-resolution glucose data this research will provide valuable insights into the best practices for managing blood sugar in patients receiving steroid injections Our goal is to improve treatment strategies particularly for diabetic patients ensuring safer and more effective pain management
The studys primary objective is to determine how often steroid-induced hyperglycemia occurs how severe it is and how long it lasts Study will also investigate whether certain factors-such as the type of steroid dosage or the patients underlying conditions-affect blood sugar responses Additionally the study will assess how the use of the CGM device may improve overall patient care reduce the need for emergency interventions and potentially lower healthcare costs by preventing complications
By gathering high-resolution glucose data this research will provide valuable insights into the best practices for managing blood sugar in patients receiving steroid injections Our goal is to improve treatment strategies particularly for diabetic patients ensuring safer and more effective pain management
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None